phenanthridone has been researched along with Alloxan Diabetes in 1 studies
phenanthridone: coal tar derivative; structure given in first source
phenanthridone : A member of the class of phenanthridines that is phenanthridine with an oxo substituent at position 6. A poly(ADP-ribose) polymerase (PARP) inhibitor, it has been shown to exhibit immunosuppressive activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferraris, D | 1 |
| Ficco, RP | 1 |
| Dain, D | 1 |
| Ginski, M | 1 |
| Lautar, S | 1 |
| Lee-Wisdom, K | 1 |
| Liang, S | 1 |
| Lin, Q | 1 |
| Lu, MX | 1 |
| Morgan, L | 1 |
| Thomas, B | 1 |
| Williams, LR | 1 |
| Zhang, J | 1 |
| Zhou, Y | 1 |
| Kalish, VJ | 1 |
1 other study available for phenanthridone and Alloxan Diabetes
| Article | Year |
|---|---|
Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries.
Topics: Animals; Benzimidazoles; Benzodiazepines; Binding Sites; Brain Ischemia; Caco-2 Cells; Diabetes Mell | 2003 |